Key bottlenecks in M/XDR-TB control and patient care
WHO/Dominic Chavez
Christopher Alabado receives his daily injection of capreomycin at the International Center for Tuberculosis in Manila, Philippines.
A number of key bottlenecks, which are common across many affected countries planning and beginning to implement the M/XDR-TB response, will require political decisions within the health system as a whole to overcome. These bottlenecks will be addressed in Beijing as follows:
- 1. Forecasting the control of MDR-TB epidemics
- 2. Addressing the gaps in TB control
- 3. Providing M/XDR-TB management and care
- 4. Addressing the health workforce crisis
- 5. Responding to the laboratory bottleneck
- 6. Ensuring access to quality-assured anti-TB medicines
- 7. Restricting the availability of anti-TB medicines
- 8. Prioritizing TB infection control
- 9. Maximizing research opportunities to address M/XDR-TB
- 10. Financing M/XDR-TB control and care
-
-
Download the complete document
pdf, 1.25Mb -
Annex 1: urgent actions needed to prevent and manage M/XDR-TB
pdf, 131kb
